Linganisha mbinu

	Betri ya Tathmini ya Mbele	Kiwango cha Tathmini ya Ugonjwa wa Alzheimer-Cognitive
Nyanja	Neurosaikolojia	Neurosaikolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2000	1984
Mwanzilishi	Bruno Dubois	William Rosen
Aina	Clinician-administered neuropsychological battery for frontal lobe function	Clinician-administered cognitive scale for Alzheimer's disease
Chanzo asilia	Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A Frontal Assessment Battery at bedside. Neurology, 55(11), 1621-1626.	Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141(11), 1356-1364.
Majina mbadala	FAB, Frontal Battery	ADAS-Cog, ADAS-Cog14, ADAS-Cog13
Zinazohusiana	5	5
Muhtasari	The Frontal Assessment Battery (FAB) is a brief, clinician-administered neuropsychological battery designed to assess frontal lobe function and executive abilities at the bedside. Developed by Dubois and colleagues at the Salpêtrière Hospital in Paris in 2000, the FAB consists of six subtests measuring conceptualization, mental flexibility, motor planning, inhibitory control, and verbal fluency. The FAB is particularly sensitive to frontotemporal dementia, Parkinson's disease with cognitive decline, and other conditions affecting prefrontal function.	The Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) is a clinician-administered cognitive assessment instrument designed specifically to measure cognitive decline in Alzheimer's disease. Developed by Rosen, Mohs, and Davis in 1984 and published in the American Journal of Psychiatry, the ADAS-Cog has become the gold standard outcome measure in pharmaceutical trials of antidementia drugs. It is sensitive to disease progression and capable of detecting cognitive change over periods as brief as 6–12 months.